What is Behcet's syndrome? 

Behcet's syndrome is classically characterized as  a triad of symptoms  that include recurring crops of mouth ulcers (aphthous ulcers), genital ulcers, and  inflammation of a specialized area around  the pupil  of the eye (the uvea).  The inflammation of the area of the eye that is around the pupil is called uveitis. Behcet's syndrome is also sometimes referred to as Behcet's disease. 

The cause of Behcet's syndrome is not known. The disease is more frequent and severe  in patients from  the Eastern Mediterranean and Asia than those of European descent. Both inherited (genetic) and environmental factors, such as microbe infections, are suspected to be factors that contribute to  the development of Behcet's syndrome. Behcet's syndrome is not felt to be contagious. 

What are symptoms  of Behcet's syndrome?

The symptoms  of Behcet's syndrome depend on  the area of the body affected. Behcet's syndrome can involve inflammation of many areas of the body. These areas  include the arteries that supply  blood to the body's tissues. Behcet's syndrome can also affect the veins that take the blood back to the lungs to replenish the oxygen content. Other areas of body that can be affected by the  inflammation of Behcet's syndrome include  the back of the eyes (retina), brain, joints, skin,  and bowels.

The mouth and genital ulcers are generally painful and recur  in crops (many shallow ulcers at  the same time). They range  in size from a few millimeters to 20 millimeters in diameter. The mouth ulcers occur on  the gums, tongue, and inner lining of the mouth. The genital ulcers occur on the scrotum  and penis of males  and vulva of women  and can leave scars. 

Inflammation of the eye, which can involve the front of the eye (uvea) causing uveitis,  or the back of the eye (retina) causing retinitis, can lead  to blindness. Symptoms of eye inflammation include pain, blurred vision, tearing, redness, and pain when looking at bright lights. It is very important for patients to  have this sensitive area monitored by an eye specialist (ophthalmologist). 

If the arteries become inflamed (arteritis) in patients with Behcet's syndrome, it can lead to death  of the tissues whose oxygen supply depends  on these vessels. This could cause a stroke if affecting the brain, belly  pain if affecting the bowel, etc. When veins become inflamed (phlebitis), the inflammation can involve large veins that develop blood clots which can loosen to cause pulmonary embolism. 

Symptoms of inflammation of the brain or tissue that covers the brain (meninges) include headaches, neck stiffness, and  is often associated with fever. Inflammation of the brain (encephalitis) and/or the meninges (meningitis) can cause damage to nervous tissue and lead to weakness or impaired function of portions of the body. This can result in confusion and coma. Typically these features occur later in the disease course, years after the diagnosis. 

Joint inflammation (arthritis) can lead to swelling, stiffness, warmth, pain, and tenderness of joints in patients with  Behcet's syndrome. This occurs in about half of patients with  Behcet's syndrome at sometime during their lives. Knees, wrists, ankles, and elbows are the most common joints affected. 

The skin of patients with  Behcet's syndrome can develop areas  of inflammation which spontaneously appear as raised, tender, reddish nodules (erythema nodosum), typically on the front of the legs. Some patients with Behcet's syndrome develop  a peculiar red or blistery skin reaction in places where they have been pierced by blood-drawing needles (see pathergy test in diagnosis section below). Recent research has  found that acne occurs more frequently  in patients  with Behcet's syndrome that also have arthritis as a manifestation. 

Ulcerations  can occur at any location  in the stomach, large or small bowel  in patients with  Behcet's disease. 

How is Behcet's syndrome diagnosed? 

Behcet's syndrome is diagnosed based on  the finding of recurrent  mouth ulcerations combined with any two of  the following:  eye inflammation, genital ulcerations, or skin abnormalities mentioned above. A special skin test called a pathergy test can  also suggest Behcet's syndrome. (The other criteria above are still required for ultimate diagnosis.) This test consists  of pricking the  skin of the forearm with a sterile needle. The test is called positive  and suggests  Behcet's syndrome when the puncture causes  a sterile red nodule or pustule that is greater than two millimeters in diameter at 24 to 48 hours. 

Tests such as skin biopsy, lumbar puncture, MRI scan of  the brain,  and bowel tests are considered based upon symptoms that are present. 

What is the treatment of Behcet's syndrome? 

The treatment of Behcet's syndrome depends on  the severity and the location  of its manifestations in an individual patient. 

Steroid (cortisone) gels, pastes (such as Kenolog in Orabase) and creams can be helpful for  the mouth  and genital ulcers. Colchicine can also minimize recurrent ulcerations. Mouth and genital ulcers healed  and were reported at a national meeting of the American College of Rheumatology as  less frequent in nine or 12 patients who were treated with Trental (pentoxifylline). Trental also seemed to maintain  the healed ulcers for up to the 29 months of the study. The effectiveness of Trental, the researchers said, seemed to be enhanced by the combination with colchicine in some patients. 

Joint inflammation can require nonsteroidal anti-inflammatory drugs (such as ibuprofen and others) or oral steroids. Colchicine and oral and injectable cortisone are used for inflammation involving the joints, eyes, skin, and brain. Sulfasalazine (Azulfidine) has been effective in some patients for arthritis. 

Bowel disease is treated with oral steroids and sulfasalazine. 

Diligent treatment of eye inflammation is essential. Patients with eye symptoms or a history of eye inflammation should be monitored by an ophthalmologist. Recent research has reported successful management of resistant eye inflammation with new biologic medications that block a protein that plays a major role in initiating inflammation, called TNF. These TNF-blocking medications, including infliximab (Remicade) and etanercept (Enbrel), can also be helpful  for severe mouth ulcerations. 

Severe  disease of the arteries, eyes,  and brain can  be difficult to treat and require powerful medications that suppress  the immune system called immunosuppressive agents.  Immunosuppressive agents used for severe Behcet's syndrome include chlorambucil (Leukeran), azathioprine (Imuran), and cyclophosphamide (Cytoxan). Cyclosporine has been used for resistant disease. 

Recent studies suggest that thalidomide  may be of benefit for certain patients with Behcet's syndrome in treating and preventing ulcerations of the mouth and genitals. Side effects of thalidomide include promoting abnormal development of fetal growth, nerve injury (neuropathy), and hypersedation. 

Recent research further suggests that patients who have had heart-valve replacement because of severe damage as a result of inflammation can benefit by immune suppression with azathioprine and prednisone after operation. 

Trials are currently underway evaluating interferon alpha for  the treatment of eye disease in patients with Behcet's syndrome. 

Behcet's Syndrome At A Glance 

• Behcet's syndrome is associated with inflammation of various areas of the body. 
• Symptoms of  Behcet's syndrome depend on  the body areas affected. 
• Recurrent mouth ulcers are characteristic  of Behcet's syndrome. 
• Treatment of Behcet's syndrome depends on the severity  and the location of its manifestations.